1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis

BACKGROUND: Ceftriaxone–sulbactam–disodium EDTA (CSE) is being developed for Gram-negative infections caused by multidrug-resistant (MDR) bacteria. PLEA was a Phase 3, double-blind, multicenter, randomized study of CSE vs. meropenem (MR) for treatment of adults with complicated urinary tract infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandale, Pankaj, Mir, Mohd Amin, Chaudhary, Saransh, Chaudhary, Manu, Sood, Rajeev, Patil, N S, Narang, Salil, Pyasi, Anurag, Shameem, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253172/
http://dx.doi.org/10.1093/ofid/ofy210.1630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253172/
http://dx.doi.org/10.1093/ofid/ofy210.1630

Ejemplares similares